Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Microb Biotechnol ; 17(7): e14527, 2024 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-39031508

RESUMEN

Formaldehyde is a key metabolite in natural and synthetic one-carbon metabolism. To facilitate the engineering of formaldehyde-producing enzymes, the development of sensitive, user-friendly, and cost-effective detection methods is required. In this study, we engineered Escherichia coli to serve as a cellular biosensor capable of detecting a broad range of formaldehyde concentrations. Using both natural and promiscuous formaldehyde assimilation enzymes, we designed three distinct E. coli growth biosensor strains that depend on formaldehyde for cell growth. These strains were engineered to be auxotrophic for one or several essential metabolites that could be produced through formaldehyde assimilation. The respective assimilating enzyme was expressed from the genome to compensate the auxotrophy in the presence of formaldehyde. We first predicted the formaldehyde dependency of the biosensors by flux balance analysis and then analysed it experimentally. Subsequent to strain engineering, we enhanced the formaldehyde sensitivity of two biosensors either through adaptive laboratory evolution or modifications at metabolic branch points. The final set of biosensors demonstrated the ability to detect formaldehyde concentrations ranging approximately from 30 µM to 13 mM. We demonstrated the application of the biosensors by assaying the in vivo activity of different methanol dehydrogenases in the most sensitive strain. The fully genomic nature of the biosensors allows them to be deployed as "plug-and-play" devices for high-throughput screenings of extensive enzyme libraries. The formaldehyde growth biosensors developed in this study hold significant promise for advancing the field of enzyme engineering, thereby supporting the establishment of a sustainable one-carbon bioeconomy.


Asunto(s)
Técnicas Biosensibles , Escherichia coli , Formaldehído , Ingeniería Metabólica , Formaldehído/metabolismo , Técnicas Biosensibles/métodos , Escherichia coli/genética , Escherichia coli/metabolismo , Escherichia coli/crecimiento & desarrollo , Ingeniería Metabólica/métodos , Oxidorreductasas de Alcohol/metabolismo , Oxidorreductasas de Alcohol/genética , Biotecnología/métodos
2.
Nat Commun ; 14(1): 2682, 2023 05 09.
Artículo en Inglés | MEDLINE | ID: mdl-37160875

RESUMEN

Formate can be envisioned at the core of a carbon-neutral bioeconomy, where it is produced from CO2 by (electro-)chemical means and converted into value-added products by enzymatic cascades or engineered microbes. A key step in expanding synthetic formate assimilation is its thermodynamically challenging reduction to formaldehyde. Here, we develop a two-enzyme route in which formate is activated to formyl phosphate and subsequently reduced to formaldehyde. Exploiting the promiscuity of acetate kinase and N-acetyl-γ-glutamyl phosphate reductase, we demonstrate this phosphate (Pi)-based route in vitro and in vivo. We further engineer a formyl phosphate reductase variant with improved formyl phosphate conversion in vivo by suppressing cross-talk with native metabolism and interface the Pi route with a recently developed formaldehyde assimilation pathway to enable C2 compound formation from formate as the sole carbon source in Escherichia coli. The Pi route therefore offers a potent tool in expanding the landscape of synthetic formate assimilation.


Asunto(s)
Formiatos , Fosfatos , Carbono , Escherichia coli/genética , Formaldehído
3.
Metab Eng ; 76: 215-224, 2023 03.
Artículo en Inglés | MEDLINE | ID: mdl-36804222

RESUMEN

One-carbon (C1) compounds such as methanol, formate, and CO2 are alternative, sustainable microbial feedstocks for the biobased production of chemicals and fuels. In this study, we engineered the carbon metabolism of the industrially important bacterium Pseudomonas putida to modularly assimilate these three substrates through the reductive glycine pathway. First, we demonstrated the functionality of the C1-assimilation module by coupling the growth of auxotrophic strains to formate assimilation. Next, we extended the module in the auxotrophic strains from formate to methanol-dependent growth using both NAD and PQQ-dependent methanol dehydrogenases. Finally, we demonstrated, for the first time, engineered CO2-dependent formation of part of the biomass through CO2 reduction to formate by the native formate dehydrogenase, which required short-term evolution to rebalance the cellular NADH/NAD + ratio. This research paves the way to further engineer P. putida towards full growth on formate, methanol, and CO2 as sole feedstocks, thereby substantially expanding its potential as a sustainable and versatile cell factory.


Asunto(s)
Pseudomonas putida , Pseudomonas putida/genética , Pseudomonas putida/metabolismo , Glicina/metabolismo , Metanol/metabolismo , Dióxido de Carbono/metabolismo , NAD/genética , Formiatos/metabolismo , Carbono
4.
Adv Biochem Eng Biotechnol ; 180: 299-350, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-35364693

RESUMEN

In recent years the reductive glycine pathway (rGlyP) has emerged as a promising pathway for the assimilation of formate and other sustainable C1-feedstocks for future biotechnology. It was originally proposed as an attractive "synthetic pathway" to support formatotrophic growth due to its high ATP efficiency, linear structure, and limited overlap with native pathways in most microbial hosts. Here, we present the current state of research on this pathway including breakthroughs on its engineering. Different variants of the rGlyP are discussed, including its core module for formate to glycine conversion, as well as varying modules for substrate conversion to formate, and glycine assimilation routes. Very recently, the rGlyP has been successfully implemented for synthetic formatotrophic growth, as well as for growth on methanol, in some bacterial hosts. We discuss the engineering strategies employed in these studies, including growth-coupled selection of functional pathway modules. We also compare the rGlyP to other natural and synthetic C1-assimilation pathways. Finally, we provide an outlook on open challenges and opportunities for the rGlyP, including its engineering into more biotechnological hosts, as well as the still-to-be realized production of value-added chemicals via this pathway. We expect that further research on the rGlyP will support the efficient use of sustainable C1-substrates in bioproduction.


Asunto(s)
Glicina , Ingeniería Metabólica , Biotecnología , Formiatos/metabolismo , Glicina/metabolismo
5.
Biotechnol Bioeng ; 117(11): 3422-3434, 2020 11.
Artículo en Inglés | MEDLINE | ID: mdl-32658302

RESUMEN

An efficient in vivo regeneration of the primary cellular resources NADH and ATP is vital for optimizing the production of value-added chemicals and enabling the activity of synthetic pathways. Currently, such regeneration routes are tested and characterized mainly in vitro before being introduced into the cell. However, in vitro measurements could be misleading as they do not reflect enzyme activity under physiological conditions. Here, we construct an in vivo platform to test and compare NADH regeneration systems. By deleting dihydrolipoyl dehydrogenase in Escherichia coli, we abolish the activity of pyruvate dehydrogenase and 2-ketoglutarate dehydrogenase. When cultivated on acetate, the resulting strain is auxotrophic to NADH and ATP: acetate can be assimilated via the glyoxylate shunt but cannot be oxidized to provide the cell with reducing power and energy. This strain can, therefore, serve to select for and test different NADH regeneration routes. We exemplify this by comparing several NAD-dependent formate dehydrogenases and methanol dehydrogenases. We identify the most efficient enzyme variants under in vivo conditions and pinpoint optimal feedstock concentrations that maximize NADH biosynthesis while avoiding cellular toxicity. Our strain thus provides a useful platform for comparing and optimizing enzymatic systems for cofactor regeneration under physiological conditions.


Asunto(s)
Técnicas Biosensibles/métodos , Escherichia coli , NAD/metabolismo , Adenosina Trifosfato/metabolismo , Oxidorreductasas de Alcohol/genética , Oxidorreductasas de Alcohol/metabolismo , Metabolismo Energético/genética , Escherichia coli/enzimología , Escherichia coli/genética , Escherichia coli/metabolismo , Proteínas de Escherichia coli/genética , Proteínas de Escherichia coli/metabolismo , Etanol/metabolismo , Formiato Deshidrogenasas/genética , Formiato Deshidrogenasas/metabolismo , Modelos Biológicos
6.
Nat Chem Biol ; 16(5): 538-545, 2020 05.
Artículo en Inglés | MEDLINE | ID: mdl-32042198

RESUMEN

Engineering a biotechnological microorganism for growth on one-carbon intermediates, produced from the abiotic activation of CO2, is a key synthetic biology step towards the valorization of this greenhouse gas to commodity chemicals. Here we redesign the central carbon metabolism of the model bacterium Escherichia coli for growth on one-carbon compounds using the reductive glycine pathway. Sequential genomic introduction of the four metabolic modules of the synthetic pathway resulted in a strain capable of growth on formate and CO2 with a doubling time of ~70 h and growth yield of ~1.5 g cell dry weight (gCDW) per mol-formate. Short-term evolution decreased doubling time to less than 8 h and improved biomass yield to 2.3 gCDW per mol-formate. Growth on methanol and CO2 was achieved by further expression of a methanol dehydrogenase. Establishing synthetic formatotrophy and methylotrophy, as demonstrated here, paves the way for sustainable bioproduction rooted in CO2 and renewable energy.


Asunto(s)
Escherichia coli/crecimiento & desarrollo , Escherichia coli/metabolismo , Formiatos/metabolismo , Glicina/metabolismo , Metanol/metabolismo , Oxidorreductasas de Alcohol/genética , Oxidorreductasas de Alcohol/metabolismo , Dióxido de Carbono/metabolismo , Escherichia coli/genética , Genoma Bacteriano , Ingeniería Metabólica/métodos , Redes y Vías Metabólicas , Microorganismos Modificados Genéticamente , Mutación , Biología Sintética/métodos
7.
Methods Enzymol ; 608: 329-367, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-30173769

RESUMEN

The introduction of synthetic pathways into microbes often requires substantial modifications of the host metabolism. Here, we present and discuss key experimental aspects required for modifying microbial central metabolism. We introduce the concept of dividing pathways into metabolic modules, the activity of which can be selected for and optimized in dedicated gene-deletion strains. We provide a comprehensive methodology for systematic pathway implementation in vivo, ranging from gene-deletion methods for the creation of selection strains to cloning strategies that allow fine-tuned expression of individual pathway enzymes in synthetic operons. We further describe pathway testing and validation via high-throughput growth experiments and 13C-labeling measurements. While we focus on Escherichia coli as bacterial host, the holistic approach we present could be easily adapted for the metabolic engineering of other microbes.


Asunto(s)
Escherichia coli/genética , Ingeniería Metabólica/métodos , Vías Biosintéticas , Escherichia coli/enzimología , Escherichia coli/metabolismo , Eliminación de Gen , Expresión Génica , Microbiología Industrial/métodos , Redes y Vías Metabólicas , Biología Sintética/métodos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA